title: Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL): what makes T-ALL TYK?
authors.affiliation: Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Vic., Australia.
authors.forename: David J
authors.initials: DJ
authors.lastname: Curtis
mesh_terms: D006801:Humans; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
keywords: T-cell acute lymphoblastic leukaemia; TYK2; inhibitor